This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignees: Ono Pharmaceutical Co., Ltd., Tokushima University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 575 
1 out of 42 
Years Active: 2025
Title: Taku Okazaki: Innovator in Immunosuppressive Agents
Introduction
Taku Okazaki is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of immunology, particularly through his innovative work on immunosuppressive agents. His research focuses on enhancing the effectiveness of treatments that modulate immune responses.
Latest Patents
Taku Okazaki holds 1 patent for an immunosuppressive agent. This agent contains a substance selected from anti-CD80 antibodies and anti-PD-L1 antibodies, which promotes binding between PD-L1 and PD-1. This innovation has the potential to improve therapeutic strategies for various immune-related conditions.
Career Highlights
Throughout his career, Taku Okazaki has worked with prominent organizations, including Ono Pharmaceutical Co., Ltd. and Tokushima University. His experience in these institutions has allowed him to advance his research and contribute to the development of new medical therapies.
Collaborations
Taku Okazaki has collaborated with esteemed colleagues such as Daisuke Sugiura and Takeo Maeda. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
Taku Okazaki's work in the field of immunosuppressive agents exemplifies the importance of innovation in medical science. His contributions are paving the way for new treatments that could significantly benefit patients with immune-related disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile